Eosinophilic esophagitis: literature review and original case presentation
Abstract
The aim of publication. To show features of clinical pattern, difficulties of diagnostics and treatment of eosinophilic esophagitis at the example of clinical case.
Features of clinical case. In young patient the diagnosis of eosinophilic esophagitis at stage of complications (esophageal stricture) has been made 20 years after manifestation of disease. Conservative treatment by topical corticosteroids did not result in resolution of dysphagia and morphological changes of esophageal wall that required a course of systemic corticosteroids with further dilatation of the esophagus recommended to the patient. Poor knowledge of this disease by internists and endoscopists often results in establishment of incorrect diagnoses, late diagnostics, development of complications requiring surgical interventions, decrease of quality of life of patients.
Conclusion. Eosinophilic esophagitis is chronic immune antigen-mediated inflammatory disease of the esophagus with still obscure etiopathogenesis. Diagnostics is based on characteristic clinical pattern of dysphagia that is always combined to eosinophilic infiltration of esophageal mucosa at histological study. Treatment options of eosinophilic esophagitis are limited now and include strict eliminative diet and application of steroid hormones.
About the Authors
V. T. Ivashkin
ГБОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Росздрава
Russian Federation
Russian Federation
Ye. K. Baranskaya
ГБОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Росздрава
Russian Federation
Russian Federation
V. O. Kaybysheva
ГБОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Росздрава
Russian Federation
Russian Federation
Ye. V. Ivanova
РГМУ им. Н.И. Пирогова
Russian Federation
Russian Federation
Ye. D. Fedorov
РГМУ им. Н.И. Пирогова
Russian Federation
Russian Federation
References
1. Abu-Sultaneh S.M., Durst P., Maynard V. et al. Fluticasone and food allergen elimination reverse subepithelial fibrosis in children with eosinophilic esophagitis // Dig. Dis. Sci. – 2011. – Vol. 56. – P. 97–102.
2. Aceves S.S., Newbury R.O., Dohil R. et al. Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder // J. Clin. Gastroenterol. – 2007. – Vol. 41. – P. 252–256.
3. Atkins D., Kramer R., Capocelli K. et al. Eosinophilic esophagitis: the newest esophageal inflammatory disease // Nat. Rev. Gastroenterol. Hepatol. – 2009 – Vol. 6, N 5. – P. 267–278.
4. Belvisi M. Regulation of inflammatory cell function by corticosteroids // Proc. Am. Thorac. – Soc. – 2004. – N 1. – P. 207–214.
5. Blanchard C., Rothenberg E. Basics pathogenesis of eosinophilic esophagitis // Gastrointest. Endosc. Clin. N. Am. – 2008. – Vol. 18, N 1. – P. 133–143.
6. Blanchard C., Stucke E., Burwinkel K. et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis // J. Immunol. – 2010. – Vol. 184. – P. 4033–4041.
7. Blanchard C., Wang N., Stringer K. et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis // J. Clin. Invest. – 2006. – Vol. 116, N 2. – P. 536–547.
8. Bohm M., Richter J., Kelsen S. et al. Esophageal dilation: simple and effective treatment for adults with eosinophilic esophagitis and esophageal rings and narrowing // Dis. Esophagus. – 2010. – Vol. 23. – P. 377–385.
9. Chehade M., Sampson H. Epidemiology and etiology of eosinophilic esophagitis // Gastrointest. Endosc. Clin. N. Am. – 2008. – Vol. 18. – P. 33–44.
10. Dalby K., Nielsen R., Kruse-Andersen S. et al. Gastroesophageal reflux disease and eosinophilic esophagi+tis in infants and children. A study of esophageal pH, multiple intraluminal impedance and endoscopic ultrasound // Scand. J. Gastroenterol. – 2010. – Vol. 45. – P. 1029–1035.
11. Dellon E., Gibbs W., Fritchie K. et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease // Clin. Gastroenterol. Hepatol. – 2009. – Vol. 7. – P. 1305–1313.
12. Erwin E., James H., Gutekunst H. et al. Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis // Ann. Allergy Asthma Immunol. – 2010. – Vol. 104. – P. 496–502.
13. Fox V.L. Eosinophilic esophagitis: endoscopic findings // Gastrointest. Endosc. Clin. N. Am. – 2008. – Vol. 18. – P. 45–57.
14. Furuta G.T. Eosinophilic esophagitis: Update on clinicopathological manifestations and pathophysiology // Curr. Opin. Gastroenterol. – 2011. – Vol. 27, N 4. – P. 383–388.
15. Gonsalves N., Policarpio-Nicolas M., Zhang Q. et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis // Gastrointest. Endosc. – 2006. – Vol. 64, N 3. – P. 313–322.
16. Hirano I. Eosinophilic esophagitis – What do we know after 15 years? Brief summary of AGA PG course, 2010.
17. Jung K., Gundersen N., Kopacova J. et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis // Gastrointest. Endosc. – 201. – Vol. 73. – P. 15–21.
18. Kita H. The eosinophil: a cytokine-producing cell? // J. Allergy Clin. Immunol. – 1996. –Vol. 97, N 4. – P. 889–892.
19. Kottyan L., Collier A., Cao K. et al. Eosinophil viability is increased by acidic pH in a cAMP and GPR65dependent manner // Blood. – 2009. – Vol. 114. – P. 2774–2782.
20. Krarup A., Villadsen G., Mejlgaard E. et al. Acid hypersensitivity in patients with eosinophilic esophagitis
21. // Scand. J. Gastroenterol. – 2010. – Vol. 45. – P.273–281.
22. Lewis R., Austen K., Soberman R. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases // N. Engl. J. Med. – 1990 – Vol. 323, N 10. – P. 645–655.
23. Liacouras C., Furuta G., Hirano I. et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults // J. Allergy Clin. Immunol. – 2011. – Vol. 128, N 1. – P. 3–20.
24. Mattes J., Yang M., Mahalingam S. et al. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma // J. Exp. Med. – 2002. – Vol. 195, N 11. – P. 1433–1444.
25. Moawad F., Veerappan G., Lake J. et al. Correlation between eosinophilic esophagitis and aeroallergens // Aliment. Pharmacol. Ther. – 2010. – Vol. 31. – P. 509–515.
26. Noel R., Putnam P., Rothenberg M. Eosinophilic esophagitis // N. Engl. J. Med. – 2004. – Vol. 351, N 9. – P. 940–941.
27. Odze R. Pathology of eosinophilic esophagitis: what the clinician needs to know // Am. J. Gastroenterol. – 2009. – Vol. 104. – P. 485–490.
28. Prasad G., Alexander J., Schleck C. et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted county, Minnesota // Clin. Gastroenterol. Hepatol. – 2009. – Vol. 7, N 10. – P. 1055–1116.
29. Remedios M., Jones D., Kerlin P. Eosinophilic esophagitis: epidemiology, pathogenesis and management // Drugs. – 2011. – Vol. 71, N 5. – P. 527–567.
30. Rothenberg M., Spergel J., Sherrill J. et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis // Nat. Genet. – 2010. – Vol. 42, N 4. – P. 289–380.
31. Roy-Ghanta S., Larosa D., Katzka D. Atopic characteristics of adult patients with eosinophilic esophagitis
32. // Clin. Gastroenterol. Hepatol. – 2008. – Vol. 6. – P. 531–535.
33. Schoepfer A., Gonsalves N., Bussmann C. et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation // Am. J. Gastroenterol. – 2010. – Vol. 105. – P. 1062–1070.
34. Shah A., Kagalwalla A., Gonsalves N. et al. Histopathologic variability in children with eosinophilic esophagitis // Am. J. Gastroenterol. – 2009. – Vol. 104, N 3. – P. 716–737.
35. Sherrill J., Gao P., Stucke E. et al. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis // J. Allergy Clin. Immunol. – 2010. – Vol. 126. – P. 160–165.
36. Shi H., Humbles A., Gerard C. et al. Lymph node trafficking and antigen presentation by endobronchial eosinophils // J. Clin. Invest. – 2000. – Vol. 105, N 7. – P. 945–953.
37. Shinkai K., Mohrs M., Locksley R. Helper T cells regulate type-2 innate immunity in vivo // Nature. – 2002. – Vol. 420. – P. 825–829.
38. Spergel J. Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients // Curr. Opin. Allergy Clin. Immunol. – 2007. – Vol. 7. – P. 274–278.
39. Straumann A., Bussmann C., Zuber M. et al. Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients // Clin. Gastroenterol. Hepatol. – 2008. – Vol. 6. – P. 598–600.
40. Straumann A., Simon H. Eosinophilic esophagitis: escalating epidemiology? // J. Allergy Clin. Immunol. –
41. – Vol. 115. – P. 418.
42. Zuo L., Fulkerson P., Finkelman F. et al. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway // J. Immunol. – 2010. – Vol. 185. – P. 660–669.
Review
For citations:
Ivashkin V.T., Baranskaya Ye.K., Kaybysheva V.O., Ivanova Ye.V., Fedorov Ye.D. Eosinophilic esophagitis: literature review and original case presentation. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2012;22(1):71-81. (In Russ.)
Views:
80
Email this article 
